Amicus Therapeutics, Inc. (FOLD)
14.34
0.00 (0.00%)
USD |
NASDAQ |
Mar 04, 13:41
Amicus Therapeutics Cash from Investing (TTM) : -46.43M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | -414.24M |
| CorMedix, Inc. | -312.03M |
| Krystal Biotech, Inc. | -58.42M |
| MannKind Corp. | -304.80M |
| Keros Therapeutics, Inc. | -1.706M |